XML 20 R10.htm IDEA: XBRL DOCUMENT v3.20.2
Earnings (Loss) Per Share
 9 Months Ended
Oct. 30, 2020
Earnings Per Share Basic And Diluted [Abstract]  
Earnings (Loss) Per Share

NOTE 3. EARNINGS (LOSS) PER SHARE

 

The numerator for both basic and diluted EPS is net income (loss). The denominator for basic EPS is based upon the number of weighted average shares of Lands’ End common stock outstanding during the reporting periods. The denominator for diluted EPS is based upon the number of weighted average shares of Lands' End common stock and common stock equivalents outstanding during the reporting periods using the treasury stock method in accordance with GAAP. Potentially dilutive securities for the diluted EPS calculations consist of nonvested equity shares of common stock and in-the-money outstanding options where the current stock price exceeds the option strike price, if any, to purchase the Company’s common stock.

 

The following table summarizes the components of basic and diluted EPS:

 

 

 

13 Weeks Ended

 

 

39 Weeks Ended

 

(in thousands, except per share amounts)

 

October 30, 2020

 

 

November 1, 2019

 

 

October 30, 2020

 

 

November 1, 2019

 

Net income (loss)

 

$

7,176

 

 

$

3,606

 

 

$

(9,091

)

 

$

(6,226

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic weighted average common shares outstanding

 

 

32,605

 

 

 

32,371

 

 

 

32,551

 

 

 

32,333

 

Dilutive effect of stock awards

 

 

643

 

 

 

27

 

 

 

—

 

 

 

—

 

Diluted weighted average common shares outstanding

 

 

33,248

 

 

 

32,398

 

 

 

32,551

 

 

 

32,333

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic income (loss) per share

 

$

0.22

 

 

$

0.11

 

 

$

(0.28

)

 

$

(0.19

)

Diluted income (loss) per share

 

$

0.22

 

 

$

0.11

 

 

$

(0.28

)

 

$

(0.19

)

 

 

Stock awards are considered anti-dilutive based on the application of the treasury stock method or in the event of a net loss. There were 570,364, 653,235, 1,213,317 and 763,163 anti-dilutive shares excluded from the diluted weighted average shares outstanding for Third Quarter 2020, Third Quarter 2019, Year-to-Date 2020 and Year-to-Date 2019, respectively.